Compounds > deferoxamine

deferoxamine and cyclin d1

deferoxamine has been researched along with cyclin d1 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Ajchenbaum, F; Ando, K; DeCaprio, JA; Griffin, JD1
Gao, J; Lovejoy, D; Richardson, DR1
Lee, HC; Zhang, L; Zhu, Y1
Joung, YH; Kim, SY; Lee, KJ; Lee, MY; Lim, EJ; Moon, WK; Park, DK; Park, EU; Park, JH; Park, T; Yang, YM; Ye, SK; Zhang, Z1
Bouchecareilh, M; Hutt, DM; Marchal, C; Roth, DM1
Babosova, O; Divoky, V; Kapralova, K; Korinek, V; Lanikova, L; Prchal, JT; Raskova Kafkova, L1
Borodkina, AV; Burova, EB; Kharchenko, MV; Lyublinskaya, OG; Nikolsky, NN; Shatrova, AN; Smirnova, IS1

Other Studies

7 other study(ies) available for deferoxamine and cyclin d1

ArticleYear
Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.
    The Journal of biological chemistry, 1993, Feb-25, Volume: 268, Issue:6

    Topics: Cell Division; Cells, Cultured; Cyclin D1; Cyclins; Deferoxamine; G1 Phase; Gene Expression Regulation; Humans; Hydroxyurea; Interleukin-2; Oncogene Proteins; Phosphotransferases; RNA, Messenger; T-Lymphocytes

1993
Effect of iron chelators with potent anti-proliferative activity on the expression of molecules involved in cell cycle progression and growth.
    Redox report : communications in free radical research, 1999, Volume: 4, Issue:6

    Topics: Antineoplastic Agents; Cell Cycle; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Deferoxamine; GADD45 Proteins; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Iron Chelating Agents; Nuclear Proteins; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Retinoblastoma Protein; Tumor Cells, Cultured

1999
An examination of heme action in gene expression: heme and heme deficiency affect the expression of diverse genes in erythroid k562 and neuronal PC12 cells.
    DNA and cell biology, 2002, Volume: 21, Issue:4

    Topics: Actins; Animals; Cell Cycle Proteins; Cell Differentiation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p18; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Deferoxamine; Enzyme Inhibitors; Erythropoiesis; Gene Expression Profiling; Gene Expression Regulation; Heme; Heptanoates; Humans; Iron Chelating Agents; K562 Cells; Neurons; Oligonucleotide Array Sequence Analysis; PC12 Cells; Rats; Tumor Suppressor Proteins

2002
Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells.
    Experimental & molecular medicine, 2005, Aug-31, Volume: 37, Issue:4

    Topics: Anaerobiosis; Animals; Breast Neoplasms; Cell Hypoxia; Chlorocebus aethiops; COS Cells; Cyclin D1; Deferoxamine; Female; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Phosphorylation; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Serine; Tumor Cells, Cultured; Tyrosine

2005
Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1510

    Topics: Acetylation; Blotting, Western; Cell Line, Tumor; Chromatin; Chromosomal Proteins, Non-Histone; Cyclin D1; Deferoxamine; Eukaryotic Initiation Factor-3; Gene Expression Regulation, Neoplastic; Glycine; Hepatocytes; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; Protein Biosynthesis; Protein Processing, Post-Translational; RNA, Small Interfering; Vorinostat

2017
Iron chelation and 2-oxoglutarate-dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:11

    Topics: Amino Acids, Dicarboxylic; Cell Hypoxia; Cell Line, Tumor; Cyclin D1; Deferoxamine; Dioxygenases; DNA Damage; Down-Regulation; Enzyme Inhibitors; Forkhead Box Protein O3; Humans; Hydroxylation; Hypoxia-Inducible Factor-Proline Dioxygenases; Iron Chelating Agents; Iron Deficiencies; Ketoglutaric Acids; Lymphoma, Mantle-Cell; RNA, Messenger

2019
Outcomes of Deferoxamine Action on H
    International journal of molecular sciences, 2021, Jun-03, Volume: 22, Issue:11

    Topics: Apoptosis; Cell Differentiation; Cell Line; Cellular Microenvironment; Cellular Senescence; Cyclin D1; Deferoxamine; Endometrium; Female; Gene Expression Regulation, Developmental; Humans; Hydrogen Peroxide; Inflammation; Lipofuscin; Mesenchymal Stem Cells; Oxidative Stress; Reactive Oxygen Species; Regenerative Medicine; Signal Transduction

2021